Fig. 1From: Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50 V and determination of its protective efficacy against acute toxoplasmosisPlot chart showing the amount of a MHC-I b MHC-II and c B cell epitopes in 49 vaccine candidate antigensBack to article page